Announcement The Company and Shenzhen China Resources GOSUN Pharmaceuticals signed an exclusive sales contract for Ertapenem in the mainland market
· Issued by Savior Lifetec Corp.
Close
Today's Information
Provided by: Savior Lifetec Corporation
SEQ_NO
2
Date of announcement
2022/06/08
Time of announcement
17:59:21
Subject
Announcement The Company and Shenzhen China
Resources GOSUN Pharmaceuticals signed an exclusive
sales contract for Ertapenem in the mainland market
Date of events
2022/06/08
To which item it meets
paragraph 10
Statement
1.Date of occurrence of the event:2022/06/08
2.Counterparty to the contract or commitment:
Shenzhen China Resources GOSUN Pharmaceuticals Co.,Ltd
3.Relationship with the Company:None
4.Starting and ending dates (or rescission date) of the
contract or commitment:From the date of signing the contract
5.Major content (not applicable where rescinded):
The company signed a sales contract with Shenzhen China Resources GOSUN
Pharmaceuticals, authorizing the company to exclusively sell the company's
ertapenem injection products in the mainland market.
6.Restrictive covenants (not applicable where rescinded):Privacy Policy
7.Commitment (not applicable where rescinded):None
8.Any other important agreement (not applicable where rescinded):None
9.Effect on company finances and business:
Accelerating the introduction of ertapenem into the Chinese mainland
market will help increase the global market share of the company's products
10.Concrete purpose/objective:Through this cooperation project, the company
will open a new milestone in the company's mainland market sales.
11.Any other matters that need to be specified:
It can only be sold after obtaining a drug certificate in cooperation with
the sales area. For financial or business information, please refer to the
information published by the Company on the Public Information Observatory.
